These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7928258)

  • 21. Nanoscaled iodized oil emulsion as a CT contrast agent for the detection of experimental liver tumors in a rat model.
    Lim SJ; Lim JS; Choi J; Choi JY; Hyung WJ; Kim HS; Suh J; Kim KW
    Acad Radiol; 2010 Aug; 17(8):985-91. PubMed ID: 20617548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CT visualization of blood pool in rats by using long-circulating, iodine-containing micelles.
    Torchilin VP; Frank-Kamenetsky MD; Wolf GL
    Acad Radiol; 1999 Jan; 6(1):61-5. PubMed ID: 9891154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible Contrast Media Reduction with Low keV Monoenergetic Images in the Detection of Focal Liver Lesions: A Dual-Energy CT Animal Study.
    Chung YE; You JS; Lee HJ; Lim JS; Lee HS; Baek SE; Kim MJ
    PLoS One; 2015; 10(7):e0133170. PubMed ID: 26203652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of iohexol and metrizamide in dynamic CT of the upper abdomen.
    Partanen K; Kormano M; Kivimäki T; Soimakallio S
    Eur J Radiol; 1984 Aug; 4(3):227-8. PubMed ID: 6468419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Contrast material for CT of the liver and spleen--an experimental study on the safety of lipiodol-iopamidol emulsion].
    Murakami T; Hori S; Nishikawa M; Hashimoto T; Fujita N; Narumi Y; Kuroda C; Kozuka T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Dec; 49(12):1509-16. PubMed ID: 2561193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computed tomography of experimental liver abscesses using a new liposomal contrast agent.
    Dick A; Adam G; Tacke J; Prescher A; Southon TE; Günther RW
    Invest Radiol; 1996 Apr; 31(4):194-203. PubMed ID: 8721958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sonographic shift of hypervascular liver tumor on blood pool harmonic images with definity: time-related changes of contrast-enhanced appearance in rabbit VX2 tumor under extra-low acoustic power.
    Maruyama H; Matsutani S; Saisho H; Kamiyama N; Mine Y; Hirata T; Sasamata M
    Eur J Radiol; 2005 Oct; 56(1):60-5. PubMed ID: 16168266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography.
    Mattrey RF; Long DM; Multer F; Mitten R; Higgins CB
    Radiology; 1982 Dec; 145(3):755-8. PubMed ID: 7146408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The "double target sign" in liver abscess.
    Giambelluca D; Panzuto F; Giambelluca E; Midiri M
    Abdom Radiol (NY); 2018 Oct; 43(10):2885-2886. PubMed ID: 29508010
    [No Abstract]   [Full Text] [Related]  

  • 30. A new liposomal contrast medium for CT of the liver. An imaging study in a rabbit tumour model.
    Leander P
    Acta Radiol; 1996 Jan; 37(1):63-8. PubMed ID: 8611327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted polyiodinated triglycerides for hepatic computed tomography.
    Weichert JP; Longino MA; Bakan DA; Spigarelli MG; Schwendner SW; Francis IR; Counsell RE
    Invest Radiol; 1994 Jun; 29 Suppl 2():S284-5. PubMed ID: 7928257
    [No Abstract]   [Full Text] [Related]  

  • 32. Computed tomography of the abdomen.
    Bresler MJ
    Ann Emerg Med; 1986 Mar; 15(3):280-5. PubMed ID: 3511790
    [No Abstract]   [Full Text] [Related]  

  • 33. Experimental evaluation of five liver-spleen specific CT contrast agents.
    Miller DL; O'Leary T; Vucich JJ; Girton M; Vermess M; Doppman JL
    J Comput Assist Tomogr; 1983 Dec; 7(6):1022-8. PubMed ID: 6313773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposomes as carriers of iodolipid radiocontrast agents for CT scanning of the liver.
    Jendrasiak GL; Frey GD; Heim RC
    Invest Radiol; 1985 Dec; 20(9):995-1002. PubMed ID: 3000977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison between IEEC, a new biodegradable particulate contrast medium, and iohexol in a tumor model of computed tomography imaging of the liver.
    Leander P; Golman K; Strande P; Klaveness J; Besjakov J; Fält K
    Invest Radiol; 1993 Jun; 28(6):513-9. PubMed ID: 8320069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Grey-scale contrast enhancement in rabbit liver with DMP115 at different acoustic power levels.
    Maruyama H; Matsutani S; Saisho H; Kamiyama N; Yuki H; Miyata K
    Ultrasound Med Biol; 2000 Nov; 26(9):1429-38. PubMed ID: 11179617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abdominal aortography for the roentgen demonstration of the liver and spleen.
    RIGLER LG; OLFELT PC
    Am J Roentgenol Radium Ther Nucl Med; 1954 Oct; 72(4):586-96; discussion, 606-8. PubMed ID: 13197620
    [No Abstract]   [Full Text] [Related]  

  • 38. Computerised tomography and the liver.
    Kreel L
    Clin Radiol; 1977 Nov; 28(6):571-81. PubMed ID: 589911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Densitometry via CT scan of liver, spleen and kidneys with bolus-shaped liver contrast media by the intravenous route (author's transl)].
    Hübener KH
    Rofo; 1978 Sep; 129(3):289-97. PubMed ID: 151038
    [No Abstract]   [Full Text] [Related]  

  • 40. Liposomes loaded with nonionic contrast media. Hepatosplenic computed tomographic enhancement.
    Passariello R; Pavone P; Patrizio G; Di Renzi P; Mastantuono M; Giuliani S
    Invest Radiol; 1990 Sep; 25 Suppl 1():S92-4. PubMed ID: 2283272
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.